Roche Holding AG (RHHBY)
OTCMKTS · Delayed Price · Currency is USD
45.40
+0.25 (0.55%)
Oct 8, 2025, 3:59 PM EDT
Roche Holding AG Market Cap
Roche Holding AG has a market cap or net worth of $311.99 billion as of October 8, 2025. Its market cap has increased by 22.91% in one year.
Market Cap
311.99B
Enterprise Value
345.65B
Revenue
79.83B
Ranking
n/a
PE Ratio
26.31
Stock Price
$45.40
Market Cap Chart
Since January 2, 1992, Roche Holding AG's market cap has increased from 8.76B to 311.99B, an increase of 3,462.08%. That is a compound annual growth rate of 11.15%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 7, 2025 | 310.59B | 37.29% |
Dec 30, 2024 | 226.23B | -3.34% |
Dec 29, 2023 | 234.04B | -9.76% |
Dec 30, 2022 | 259.35B | -22.73% |
Dec 30, 2021 | 335.62B | 12.23% |
Dec 30, 2020 | 299.05B | 8.13% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Elite Pharmaceuticals | 686.89M |
Glass House Brands | 644.95M |
Veradigm | 511.83M |
Northwest Biotherapeutics | 382.92M |
Nika Pharmaceuticals | 333.67M |
CytoDyn | 326.79M |
American Oncology Network | 281.53M |
Silence Therapeutics | 236.17M |